Accelerate Diagnostics, Inc. (0H8E.L)
USD 0.57
(-14.24%)
USD 0.57
(-14.24%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2.55 Million USD | -22.8% |
| 2022 | 3.3 Million USD | 966.93% |
| 2021 | -381 Thousand USD | -108.54% |
| 2020 | 4.45 Million USD | 1.34% |
| 2019 | 4.4 Million USD | 810.97% |
| 2018 | 483 Thousand USD | -72.77% |
| 2017 | 1.77 Million USD | 621.14% |
| 2016 | 246 Thousand USD | 67.35% |
| 2015 | 147 Thousand USD | 20.49% |
| 2014 | 122 Thousand USD | 154.17% |
| 2013 | 48 Thousand USD | 11.11% |
| 2012 | 43.2 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 676 Thousand USD | -6.5% |
| 2024 Q1 | 723 Thousand USD | 14.22% |
| 2023 Q3 | 1.29 Million USD | 61.58% |
| 2023 Q1 | 1.01 Million USD | 20.21% |
| 2023 Q2 | 799 Thousand USD | -20.97% |
| 2023 Q4 | 633 Thousand USD | -50.97% |
| 2023 FY | 2.55 Million USD | -22.8% |
| 2022 Q4 | 841 Thousand USD | 45.25% |
| 2022 Q3 | 579 Thousand USD | -46.39% |
| 2022 Q1 | 802 Thousand USD | 124.17% |
| 2022 FY | 3.3 Million USD | 966.93% |
| 2022 Q2 | 1.08 Million USD | 34.66% |
| 2021 Q3 | 986 Thousand USD | -6.36% |
| 2021 FY | -381 Thousand USD | -108.54% |
| 2021 Q1 | 897 Thousand USD | -21.86% |
| 2021 Q4 | -3.31 Million USD | -436.51% |
| 2021 Q2 | 1.05 Million USD | 17.39% |
| 2020 FY | 4.45 Million USD | 1.34% |
| 2020 Q1 | 1.05 Million USD | -30.27% |
| 2020 Q4 | 1.14 Million USD | -11.76% |
| 2020 Q3 | 1.3 Million USD | 36.37% |
| 2020 Q2 | 954 Thousand USD | -9.57% |
| 2019 Q2 | 899 Thousand USD | 7.79% |
| 2019 FY | 4.4 Million USD | 810.97% |
| 2019 Q4 | 1.51 Million USD | 31.11% |
| 2019 Q3 | 1.15 Million USD | 28.36% |
| 2019 Q1 | 834 Thousand USD | 59.16% |
| 2018 Q2 | 975 Thousand USD | 215.53% |
| 2018 Q1 | 309 Thousand USD | -78.97% |
| 2018 FY | 483 Thousand USD | -72.77% |
| 2018 Q4 | 524 Thousand USD | -22.37% |
| 2018 Q3 | 675 Thousand USD | -30.77% |
| 2017 Q1 | 504 Thousand USD | 1192.31% |
| 2017 FY | 1.77 Million USD | 621.14% |
| 2017 Q4 | 1.46 Million USD | 130.61% |
| 2017 Q3 | 637 Thousand USD | 12.94% |
| 2017 Q2 | 564 Thousand USD | 11.9% |
| 2016 Q2 | 20 Thousand USD | -87.73% |
| 2016 Q3 | 24 Thousand USD | 20.0% |
| 2016 FY | 246 Thousand USD | 67.35% |
| 2016 Q4 | 39 Thousand USD | 62.5% |
| 2016 Q1 | 163 Thousand USD | 640.91% |
| 2015 Q2 | 19 Thousand USD | 35.71% |
| 2015 Q3 | 92 Thousand USD | 384.21% |
| 2015 FY | 147 Thousand USD | 20.49% |
| 2015 Q1 | 14 Thousand USD | -82.28% |
| 2015 Q4 | 22 Thousand USD | -76.09% |
| 2014 Q4 | 79 Thousand USD | 393.75% |
| 2014 Q3 | 16 Thousand USD | 23.08% |
| 2014 Q2 | 13 Thousand USD | -7.14% |
| 2014 Q1 | 14 Thousand USD | 16.67% |
| 2014 FY | 122 Thousand USD | 154.17% |
| 2013 Q4 | 12 Thousand USD | -7.69% |
| 2013 FY | 48 Thousand USD | 11.11% |
| 2013 Q2 | 7000.00 USD | -56.25% |
| 2013 Q1 | 16 Thousand USD | 192.18% |
| 2013 Q3 | 13 Thousand USD | 85.71% |
| 2012 Q4 | 5476.00 USD | 0.0% |
| 2012 FY | 43.2 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| QuidelOrtho Corporation | 1.49 Billion USD | 99.829% |